Page last updated: 2024-11-08

3,4-dihydroxyphenyllactic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4-dihydroxyphenyllactic acid: from S. miltiorhiza Bge; dilates coronary artery; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID439435
CHEMBL ID3392011
CHEBI ID17807
SCHEMBL ID829784
MeSH IDM0107651

Synonyms (35)

Synonym
3-(3,4-dihydroxyphenyl)lactic acid
CHEBI:17807 ,
3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid
23028-17-3
3,4-dihydroxyphenyllactic acid
C01207
unii-na8h56ym3k
na8h56ym3k ,
benzenepropanoic acid, alpha,3,4-trihydroxy-
SODIUM DANSHENSU ,
SCHEMBL829784
beta-(3,4-dihydroxylphenyl)-alpha-hydroxylpropionic acid
3-ethoxy-5-fluorophenylboronicacid
(+/-)-dan shen su
danshensu, (+/-)-
2-hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid
3-(3,4-dihydroxyphenyl)lactic acid dl-.beta.-(3,4-dihydroxyphenyl)lactic acid
.alpha.-hydroxydihydrocaffeic acid
FT-0696736
CHEMBL3392011
dl-b-(3,4-dihydroxyphenyl)lactic acid
alpha-hydroxyhydrocaffeic acid
a-hydroxyhydrocaffeic acid
dl-beta-(3,4-dihydroxyphenyl)lactic acid
2-hydroxy-3-(3,4-dihydroxyphenyl)propanoate
alpha-hydroxyhydrocaffeate
AKOS032948319
Q27102635
danshensuan a
benzenepropanoic acid, a,3,4-trihydroxy-
HY-113145
(rac)-salvianic acid a
DTXSID10865081
CS-0062272
EN300-1855882

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Test substance administered acutely to mice caused dose-dependent general behavior adverse effects and mortality with the medial lethal dose of 2356."( Acute and subchronic toxicity of danshensu in mice and rats.
Gao, Y; Li, B; Li, C; Li, G; Li, M; Liu, Z, 2009
)
0.35
" No significant adverse effects on these parameters were observed."( Study on toxicity of danshensu in beagle dogs after 3-month continuous intravenous infusion.
Gao, Y; Li, C; Li, G; Li, M; Li, S; Liu, Z; Zhu, X, 2009
)
0.35

Pharmacokinetics

ExcerptReferenceRelevance
" This validated assay is applied to the determination of Dhpl and Pal concentrations and used to take a limited view of the pharmacokinetic profile in rat serum after oral administration of Radix Salviae miltiorrhizae extract."( Simultaneous determination and pharmacokinetic studies on (3,4-Dihydroxyphenyl)-lactic acid and protocatechuic aldehyde in rat serum after oral administration of Radix Salviae miltiorrhizae extract.
Guo, DA; Li, YY; Ren, H; Wang, CS; Ye, G, 2003
)
0.32
" The established method has been successfully applied in the pharmacokinetic study and drug interaction of danshensu, ferulic acid, cryptotanshinone, and tanshinone IIA in rabbits after intravenous administration of danxiongfang, a useful compound preparation of traditional Chinese medicine."( Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in rabbit plasma by HPLC and their pharmacokinetic application in danxiongfang.
Li, X; Li, Y; Wang, L; Xu, Y; Xue, M, 2007
)
0.34
" The validated LC/MS/MS method was applied to a pharmacokinetic study in which danshen extract (containing 40 mg/g danshensu) was administered orally to rats at a single dose of 200 mg/kg in 2% water."( Determination and pharmacokinetics of danshensu in rat plasma after oral administration of danshen extract using liquid chromatography/tandem mass spectrometry.
Gao, J; Han, JP; Li, W; Li, XX; Li, ZW; Liu, CX,
)
0.13
"To develop a HPLC method for determination of the concentration of Danshensu in rat plasma and undertake comparative pharmacokinetic study of sodium danshensu and Salvia miltiorrhiza injection in rat as well as to assess the effect of other components of Salvia miltiorrhiza injection on the pharmacokinetics of Danshensu."( [Comparative pharmacokinetic study of sodium Danshensu and Salvia miltiorrhiza injection in rat].
Hong, Z; Ma, Z; Song, J; Wang, J; Wang, W, 2009
)
0.35
" The pharmacokinetic parameters were calculated with DAS2."( [Comparative pharmacokinetic study of sodium Danshensu and Salvia miltiorrhiza injection in rat].
Hong, Z; Ma, Z; Song, J; Wang, J; Wang, W, 2009
)
0.35
" The pharmacokinetic parameters such as t1/2alpha, AUC, CL had significant differences."( [Comparative pharmacokinetic study of sodium Danshensu and Salvia miltiorrhiza injection in rat].
Hong, Z; Ma, Z; Song, J; Wang, J; Wang, W, 2009
)
0.35
"The concomitant components in Salvia miltiorrhiza injection influence the pharmacokinetic properties of Danshensu and speed up its disposition and elimination."( [Comparative pharmacokinetic study of sodium Danshensu and Salvia miltiorrhiza injection in rat].
Hong, Z; Ma, Z; Song, J; Wang, J; Wang, W, 2009
)
0.35
" This method has been successfully applied in the simultaneous quantification and the pharmacokinetic studies of these six compounds in animals which were orally administered with danshen preparations."( Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic-mass spectrometry and the application to pharmacokinetics in rats.
Li, X; Li, Y; Liu, Y; Wang, L; Xue, M, 2010
)
0.36
" Pharmacokinetic parameters were than calculated with the concentration-time curve."( [Pharmacokinetic evaluation of danshensu with in vivo microdialysis in freely moving rat's jugular vein].
Cong, L; Lv, L; Zhang, H, 2010
)
0.36
"61) min, and for oral administration, Cmax = (7."( [Pharmacokinetic evaluation of danshensu with in vivo microdialysis in freely moving rat's jugular vein].
Cong, L; Lv, L; Zhang, H, 2010
)
0.36
"In vivo microdialysis in freely moving rat's jugular vein is a useful tool to obtain a complete set of free drug concentrations to determine reliable pharmacokinetic parameters."( [Pharmacokinetic evaluation of danshensu with in vivo microdialysis in freely moving rat's jugular vein].
Cong, L; Lv, L; Zhang, H, 2010
)
0.36
" Pharmacokinetic parameters were estimated using non-compartmental methods."( Pharmacokinetics of phenolic compounds of Danshen extract in rat blood and brain by microdialysis sampling.
Li, J; Wu, L; Yin, FX; Yuan, Y; Zhang, QL; Zhang, YJ, 2011
)
0.37
" Studies on the pharmacokinetic interaction between the active constituents of these two herbs (paeonol and danshensu, respectively) can provide substantial foundation for understanding its mechanism and empirical evidence to support the clinical practice."( Influence of co-administered danshensu on pharmacokinetic fate and tissue distribution of paeonol in rats.
Cao, W; Duan, L; Hu, J; Li, H; Wang, J; Wang, S; Xie, Y; Yang, Q; Zhang, B, 2012
)
0.38
" The method was successfully applied to a pharmacokinetic study in rats after an intravenous administration of Danshen injection."( Simultaneous determination of six phenolic constituents of Danshen injection in rat plasma by LC-ESI-MS and its application to a pharmacokinetic study.
Chen, XJ; Han, DE; He, JK; Li, N; Li, TT; Lu, Y; Yang, SY; Zhao, D, 2011
)
0.37
" Its pharmacokinetic parameters were as follows: tmax was 30 min, Cmax was (9."( [Study on pharmacokinetics of danshensu sodium in danshen dripping solution in Beagles].
Cheng, J; Ji, J; Ju, W; Liu, S; Liu, Z; Tan, H; Xie, L; Xu, J; Zhang, J; Zhou, L, 2012
)
0.38
"Our animal study indicated that co-administration of DG with warfarin/aspirin can cause significant pharmacokinetic and pharmacodynamic herb-drug interactions in rat."( Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin.
Fung, KP; Lau, BS; Leung, PC; Wang, S; Zhang, Z; Zhou, L; Zuo, Z, 2012
)
0.38
"To research the pharmacokinetic of Danshensu in brain via microdialysis method and automated blood technique."( [Pharmacokinetics study on Danshensu in rats by brain microdialysis and automated blood technique].
Hou, CS; Ji, LY; Sun, XB; Yang, ZH, 2013
)
0.39
" This method was successfully applied to the pharmacokinetic studies of danshensu and 4-hydroxy-3-methoxyphenyllactic acid after oral and intravenous administration of danshensu in rats."( Identification of a major metabolite of danshensu in rat urine and simultaneous determination of danshensu and its metabolite in plasma: application to a pharmacokinetic study in rats.
Chu, Y; Han, M; Li, S; Li, W; Liu, C; Ma, X; Sun, H; Wang, X; Yan, K; Zhang, H; Zhou, S; Zhu, Y, 2015
)
0.42
" A validated high performance liquid chromatography (HPLC) approach with a detection limit of 5 ng/mL was used for pharmacokinetic evaluation of ADTM in rat plasma."( Pharmacokinetic and Metabolic Studies of ADTM: A Novel Danshensu Derivative Confers Cardioprotection by HPLC-UV and LC-MS/MS.
Li, S; Li, W; Liao, K; Shan, L; Sheng, X; Wang, Y; Yu, P; Zhang, Z, 2015
)
0.42
" The validated method was successfully applied in a pharmacokinetic study in rats after intravenous administration of Shenxiong glucose injection."( A UPLC-MS/MS method for simultaneous determination of danshensu, protocatechuic aldehyde, rosmarinic acid, and ligustrazine in rat plasma, and its application to pharmacokinetic studies of Shenxiong glucose injection in rats.
Gong, Z; Huang, Y; Lan, Y; Liu, Y; Lu, Y; Wang, A; Wang, Y; Xie, Y; Zheng, L, 2015
)
0.42
"The aim of this study was to investigate the pharmacokinetic interaction between tanshinones and polyphenolics which act as the main bioactive compounds in Saliva miltiorrhiza Bunge (SMB)."( Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between them.
Duan, J; Guan, H; Qian, D; Ren, H; Shang, E; Su, S; Zhang, W, 2016
)
0.43
" The pharmacokinetic analysis of Sal B, Ros A and DA after pulmonary administration of SMPA solution to rat was performed by LC-MS/MS."( Pharmacokinetics of salvianolic acid B, rosmarinic acid and Danshensu in rat after pulmonary administration of Salvia miltiorrhiza polyphenolic acid solution.
Li, J; Liu, H; Liu, Z; Lu, P; Ma, Z; Peng, H; Xing, Y; Xue, Z; Zhang, B; Zhou, QT, 2019
)
0.51
" To investigate the pharmacokinetic interaction between FDDP and CBT after oral administration of FDDP, CBT and their combination in rats, a novel LC-MS method with segmented scan modes (multiple reaction monitoring and selected ion monitoring) and polarity (positive and negative ionization) was developed."( Segmented scan modes and polarity-based LC-MS for pharmacokinetic interaction study between Fufang Danshen Dripping Pill and Clopidogrel Bisulfate Tablet.
Du, Y; Guo, MZ; Ji, L; Ji, S; Ma, YS; Shao, X; Su, ZY; Tang, DQ; Wang, YJ; Zhao, L, 2019
)
0.51
" However, the pharmacokinetic and target tissue distribution data of QLP are still unknown."( Simultaneous determination of multiple constituents of Qi-Lin pill by UPLC-MS/MS: Applications to pharmacokinetics and testicular tissue distribution in rats.
Dai, Y; Fan, CL; Li, RX; Li, ZT; Su, ZJ; Tang, XY; Wang, XX; Wei, W; Xu, WY; Yao, ZH; Zhao, PC, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
"In the present experiment, we aimed to determine the feasibility and curative effects of emodin combined with danshensu on experimental severe acute pancreatitis (SAP) and the mutual benefit of this synergistic strategy by a prospective animal study."( Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis.
Gao, Y; Jiang, H; Li, X; Sun, B; Wang, G; Xue, D; Zhu, H, 2010
)
0.36
" SAP rats in each group received no further intervention, emodin alone, danshensu (DSS) alone, and emodin combined with DSS (EDSS), respectively."( Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis.
Gao, Y; Jiang, H; Li, X; Sun, B; Wang, G; Xue, D; Zhu, H, 2010
)
0.36
"The study was designed to explore the drug-drug interactions mechanisms mediated by OATP1B1 between traditional Chinese medicine Danshensu and rosuvastatin."( [OATP1B1 in drug-drug interactions between traditional Chinese medicine Danshensu and rosuvastatin].
Cai, J; Cao, L; Cheng, XH; Lü, YN; Peng, HW; Wei, XH; Wen, JH; Xiong, YQ; Zheng, XL; Zhou, J; Zuo, R, 2016
)
0.43
" The aim of this study was to explore the disturbed endogenous biomarkers and metabolic pathways reflecting the pharmacological activity of DSS, and mechanism of action of DSS using comprehensive metabolome analysis based on high-throughput metabolomics technology combined with ultra-high performance liquid chromatography (UPLC) coupled with quadrupole tandem time-of-flight mass spectrometry (Q-TOF-MS) and pattern recognition method."( Therapeutic effect and mechanism of danshensu on coronary heart disease using liquid chromatography combined with mass spectrometry metabolomics.
An, B; Lin, B; Lv, J; Zhang, X; Zhou, P, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
" The oral bioavailability of Danshensu F = 22."( [Pharmacokinetic evaluation of danshensu with in vivo microdialysis in freely moving rat's jugular vein].
Cong, L; Lv, L; Zhang, H, 2010
)
0.36
" ADTM's absolute oral bioavailability value was 30."( Pharmacokinetic and Metabolic Studies of ADTM: A Novel Danshensu Derivative Confers Cardioprotection by HPLC-UV and LC-MS/MS.
Li, S; Li, W; Liao, K; Shan, L; Sheng, X; Wang, Y; Yu, P; Zhang, Z, 2015
)
0.42
" The tanshinones improved the bioavailability of DSS, accelerated the eliminating rate of RA and Sal B and promoted their distribution in vivo."( Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between them.
Duan, J; Guan, H; Qian, D; Ren, H; Shang, E; Su, S; Zhang, W, 2016
)
0.43
" In the present study, an ester prodrug of Danshensu (DSS), palmitoyl Danshensu (PDSS), was synthesized with the aim to improve its oral bioavailability and prolong its half-life."( A lipophilic prodrug of Danshensu: preparation, characterization, and in vitro and in vivo evaluation.
Fan, XJ; Ge, ZQ; Guo, XJ; Qiao, B, 2017
)
0.46
" The absolute bioavailability of Sal B increased at least 10-fold after pulmonary administration, compared with oral administration."( Pharmacokinetics of salvianolic acid B, rosmarinic acid and Danshensu in rat after pulmonary administration of Salvia miltiorrhiza polyphenolic acid solution.
Li, J; Liu, H; Liu, Z; Lu, P; Ma, Z; Peng, H; Xing, Y; Xue, Z; Zhang, B; Zhou, QT, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The current findings not only identified the usefulness of sodium caprate for the improved delivery of Danshen product but also demonstrated the importance of biopharmaceutics characterization in the dosage form development of traditional Chinese medicine."( Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B.
Chow, MS; Zhou, L; Zuo, Z, 2009
)
0.35
" In the acute study, danshensu intraveniouslly administered to rats failed to induce any signs of toxicity or mortality up to a maximum practical dosage of 1500 mg/kg body weight."( Acute and subchronic toxicity of danshensu in mice and rats.
Gao, Y; Li, B; Li, C; Li, G; Li, M; Liu, Z, 2009
)
0.35
" While low dosage of sodium danshensu produced small contraction possibly through transient enhancement of Ca(2+) influx, high dosage produced significant vasodilation mainly through promoting the opening of non-selective K(+) channels and small-conductance calcium-sensitive K(+) channels in the vascular smooth muscle cells."( Biphasic effects of sodium danshensu on vessel function in isolated rat aorta.
Chen, H; Gu, BQ; Huang, P; Jin, L; Mao, SL; Wang, J; Zhang, C; Zhang, N; Zhong, MF; Zou, H, 2010
)
0.36
" Following first dosing on day 5, plasma samples were collected at different time points."( Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin.
Fung, KP; Lau, BS; Leung, PC; Wang, S; Zhang, Z; Zhou, L; Zuo, Z, 2012
)
0.38
" These results provide a meaningful basis for developing a clinical dosage regimen in the treatment of hepatic fibrosis by FZHY."( Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Liu, CH; Liu, S; Tao, YY; Wang, CH; Yang, T; Zhou, H, 2015
)
0.42
" Dosing with SAS treatment attenuated the incidence rate of leukocyte influx by inhibit increase of interleukin (IL)-1β, IL-6, monocyte chemoattractant protein-1, and tumor necrosis factor-α."( Danshensu Decreases UVB-Induced Corneal Inflammation in an Experimental Mouse Model via Oral Administration.
Chen, BY; Chen, CT; Lin, SP; Teng, MC; Wang, PH; Wu, CY; Wu, PC, 2018
)
0.48
" The Danshen granule is the pharmaceutical dosage forms of Salvia miltiorrhiza and Salvianic acid A is an essential chemical constituent of Salvia miltiorrhiza."( The attenuation of HIV-1 Tat-induced neurotoxicity by Salvianic acid A and Danshen granule.
Bao, D; Liu, H; Liu, J; Qin, T; Wang, J, 2019
)
0.51
" CETSA and isothermal dose-response fingerprint curves confirmed that DSS combined with CXCR1 in a dose-dependent manner."( CXCR1 and its downstream NF-κB inflammation signaling pathway as a key target of Guanxinning injection for myocardial ischemia/reperfusion injury.
Fan, G; He, S; Liu, J; Lyu, M; Wang, H; Xiao, G; Zhu, Y, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
2-hydroxy monocarboxylic acid
catecholsAny compound containing an o-diphenol component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (250)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (2.00)18.7374
1990's7 (2.80)18.2507
2000's62 (24.80)29.6817
2010's139 (55.60)24.3611
2020's37 (14.80)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.98 (24.57)
Research Supply Index5.54 (2.92)
Research Growth Index5.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.40%)5.53%
Reviews5 (1.98%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other247 (97.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]